Stock Analysis on Net

Uber Technologies Inc. (NYSE:UBER)

Cash Flow Statement 
Quarterly Data

The cash flow statement provides information about a company cash receipts and cash payments during an accounting period, showing how these cash flows link the ending cash balance to the beginning balance shown on the company balance sheet.

The cash flow statement consists of three parts: cash flows provided by (used in) operating activities, cash flows provided by (used in) investing activities, and cash flows provided by (used in) financing activities.

Uber Technologies Inc., consolidated cash flow statement (quarterly data)

US$ in millions

Microsoft Excel
3 months ended: Mar 31, 2026 Dec 31, 2025 Sep 30, 2025 Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Net income (loss) including non-controlling interests 282 317 6,652 1,350 1,774 6,901 2,599 1,008 (663) 1,700 219 394 (157) 600 (1,204) (2,616) (5,918) 879 (2,439) 1,112 (122)
Depreciation and amortization 191 193 195 181 178 176 186 181 194 203 205 208 207 223 227 243 254 246 218 226 212
Stock-based compensation 473 451 465 475 435 419 438 455 484 469 492 504 470 482 482 470 359 334 281 272 281
Deferred income taxes 106 (287) (4,167) 87 (412) (6,128) 124 (7) (16) (6) 16 6 10 (190) 16 14 (281) (210) (115) (487) 120
Unrealized (gain) loss on debt and equity securities, net 1,474 1,602 (1,471) 17 (51) (556) (1,664) (333) 721 (1,000) 96 (386) (320) (752) 550 1,677 5,570 (1,198) 2,031 (1,912) (63)
Impairment of equity method investment 182
Revaluation of MLU B.V. call option (11) (10) 11 (181)
Unrealized foreign currency transactions 5 10 22 (101) (51) 135 (36) 59 150 (18) 71 2 83 71 15 25 (15) 26 14 (15) 13
Other 20 (55) (16) 106 (27) 30 (7) (58) (29) (194) (20) 111 55 (3) (12) 11 18 (145) (144) 30 (1,572)
Accounts receivable (74) (109) (22) (212) (123) 246 196 (162) (422) (395) (518) (13) 168 (323) (90) (103) (26) (243) (205) (114) (35)
Prepaid expenses and other assets (212) (154) (126) (251) (497) (30) (234) (108) (322) (281) (948) (114) (119) (139) (115) 78 (20) (7) (220) 58 (67)
Collateral held by insurer 724 28 108
Operating lease right-of-use assets 62 42 46 46 43 59 44 47 46 50 47 42 52 51 47 53 42 49 39 39 38
Accounts payable 184 (106) 101 125 6 62 48 (70) 46 (22) 112 (19) (7) (53) (35) (53) 8 19 (114) 188 (3)
Accrued insurance reserves 443 581 592 812 675 658 776 692 693 576 501 588 350 251 159 192 134 26 469 48 (27)
Accrued expenses and other liabilities (541) 446 111 (20) 430 (158) (243) 141 590 (216) 740 (87) (142) (405) 483 486 (72) 177 129 206 556
Operating lease liabilities (62) (48) (54) (51) (56) (64) (76) (25) (56) (43) (47) (46) (44) (46) (81) (49) (39) (60) (54) (20) (50)
Change in assets and liabilities, net of impact of business acquisitions and disposals (200) 652 648 449 478 773 511 515 575 (331) (113) 351 258 (664) 368 604 27 (39) 768 433 520
Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities 2,069 2,566 (4,324) 1,214 550 (5,151) (448) 812 2,079 (877) 747 796 763 (844) 1,636 3,055 5,933 (986) 3,053 (1,453) (489)
Net cash provided by (used in) operating activities 2,351 2,883 2,328 2,564 2,324 1,750 2,151 1,820 1,416 823 966 1,190 606 (244) 432 439 15 (107) 614 (341) (611)
Purchases of property and equipment (65) (75) (98) (89) (74) (44) (42) (99) (57) (55) (61) (50) (57) (59) (74) (57) (62) (80) (90) (57) (71)
Purchases of non-marketable equity securities (332) (390) (95) (12) (179) (1) (56) (58) (174) (10) (42) (1) (13) (125) (54) (803)
Purchases of marketable securities (6,759) (7,502) (6,310) (5,095) (2,540) (3,020) (4,428) (3,288) (2,029) (2,844) (3,723) (1,361) (846) (1,708) (587) (190) (336)
Purchase of notes receivables (187) (55) (24) (2) (216)
Proceeds from sale of non-marketable equity securities 500
Proceeds from maturities and sales of marketable securities 6,546 6,499 6,514 4,636 2,397 4,437 1,916 1,821 2,030 2,076 1,366 1,127 500 376 1,148 447 696
Proceeds from sale of equity method investment 8 9 18 703 200 800
Proceeds from business divestiture 26
Acquisition of businesses, net of cash acquired (6) (11) (804) (59) (2,203) (31) (52) (28)
Other investing activities 30 (135) 42 (97) (146) 61 (82) (60) (21) 14 26 (11) 4 (2) (7) 4 (1) (5) 9 8
Net cash (used in) provided by investing activities (773) (1,614) 53 (1,461) (542) 1,433 (2,692) (1,676) (242) (819) (2,416) 408 (399) (1,769) 321 (54) (135) (2,268) 1,216 101 (250)
Issuance of term loans and notes, net of issuance costs 2,232 1,127 3,972 1,703 1,121 (1) 1,485
Principal repayment on term loan and notes (1,150) (1,200) (2,000) (1,973) (7) (6) (1,525) (6) (7) (1,137) (27)
Principal payments on finance leases (40) (45) (37) (28) (47) (50) (45) (35) (42) (53) (36) (42) (40) (37) (39) (46) (62) (60) (58) (61) (47)
Proceeds from the issuance of common stock under the Employee Stock Purchase Plan 63 120 53 103 45 85 33 59 40 67
Repurchases of common stock (3,011) (1,912) (1,463) (1,363) (1,785) (555) (372) (325)
Redemption of non-controlling interests (109) (851)
Proceeds from issuance and sale of subsidiary stock units 255 550 125
Other financing activities (40) 35 (70) (51) (30) 6 19 73 (52) (124) (34) 6 (51) (85) (4) (8) (51) (88) 4 30 (179)
Net cash provided by (used in) financing activities (3,091) (3,118) (538) (195) (1,862) (3,397) 1,601 (191) (100) 46 (76) 42 (107) (89) 212 5 (113) 414 1,556 36 (226)
Effect of exchange rate changes on cash and cash equivalents, and restricted cash and cash equivalents (24) 13 (27) 159 70 (179) 62 (56) (94) 89 (69) 27 16 145 (195) (118) 20 (24) (50) 51 (46)
Net increase (decrease) in cash and cash equivalents, and restricted cash and cash equivalents (1,537) (1,836) 1,816 1,067 (10) (393) 1,122 (103) 980 139 (1,595) 1,667 116 (1,957) 770 272 (213) (1,985) 3,336 (153) (1,133)

Based on: 10-Q (reporting date: 2026-03-31), 10-K (reporting date: 2025-12-31), 10-Q (reporting date: 2025-09-30), 10-Q (reporting date: 2025-06-30), 10-Q (reporting date: 2025-03-31), 10-K (reporting date: 2024-12-31), 10-Q (reporting date: 2024-09-30), 10-Q (reporting date: 2024-06-30), 10-Q (reporting date: 2024-03-31), 10-K (reporting date: 2023-12-31), 10-Q (reporting date: 2023-09-30), 10-Q (reporting date: 2023-06-30), 10-Q (reporting date: 2023-03-31), 10-K (reporting date: 2022-12-31), 10-Q (reporting date: 2022-09-30), 10-Q (reporting date: 2022-06-30), 10-Q (reporting date: 2022-03-31), 10-K (reporting date: 2021-12-31), 10-Q (reporting date: 2021-09-30), 10-Q (reporting date: 2021-06-30), 10-Q (reporting date: 2021-03-31).


The financial trajectory indicates a transition from significant operational volatility to a period of sustained and growing cash generation. Operating cash flows shifted from negative territory in early 2021 to a consistent positive trend, with net cash provided by operating activities reaching a peak of 2,883 million US dollars by December 31, 2025, and maintaining a strong level of 2,351 million US dollars through March 31, 2026.

Operating Performance and Cash Generation
Net income exhibited extreme volatility in the early periods, characterized by large fluctuations between losses and gains. However, a stabilization pattern emerged starting in 2023, with a notable surge in profitability in late 2024. This operational improvement is mirrored in the operating cash flow, which evolved from an initial deficit of 611 million US dollars in March 2021 to multi-billion dollar quarterly contributions. This growth is supported by consistent non-cash add-backs, specifically stock-based compensation, which remained relatively stable between 400 million and 500 million US dollars per quarter throughout the analyzed period.
Investment Strategy and Capital Expenditure
Investing activities are dominated by the management of marketable securities rather than heavy industrial investment. Purchases of marketable securities increased significantly over time, often exceeding 5,000 million US dollars per quarter in the 2024-2025 period, which were partially offset by proceeds from maturities and sales. Capital expenditures for property and equipment remained lean and stable, typically ranging between 40 million and 100 million US dollars per quarter, indicating a light-asset operational model.
Financing and Capital Allocation
A fundamental shift in capital allocation is observed starting in 2024. While early financing activities were characterized by the issuance of term loans and notes to support liquidity, the later periods show a strategic pivot toward shareholder returns. Common stock repurchases escalated rapidly, beginning at 325 million US dollars in June 2024 and increasing to 3,011 million US dollars by March 2026. This aggressive buyback program is funded by the strengthened operating cash flow, signaling a move from a growth-at-all-costs phase to a mature capital return phase.
Working Capital and Non-Cash Adjustments
Significant volatility is noted in deferred income taxes and unrealized gains or losses on debt and equity securities, which frequently created large discrepancies between reported net income and actual cash flow. Accrued insurance reserves showed a steady upward trend, contributing positively to cash flow from operations as these liabilities grew, peaking at 812 million US dollars in June 2025.

AI Ask an analyst for more